Clinique Dentaire
Strasbourg, 67000, France
Location status: Recruiting
Location contact
Sophie JUNG, MD
CONTACT
NCT Number: NCT06182293
Systemic sclerosis (SSc) is a rare and complex autoimmune disease. Although its etiology remains unknown, various environmental factors, including certain microorganisms, can represent potential triggers of SSc in individuals with a permissive genetic background. Patients show a wide spectrum of clinical features including periodontitis, which is an inflammatory disease of the tooth-supporting tissues resulting from dysbiosis of the periodontal microbiota guided by inflammophilic bacteria.
The microbiota plays a fundamental role in the induction, training, and function of the host immune system. Numerous studies have highlighted the impact of an altered microbiota, i.e. dysbiosis, on the pathogenesis of immune-mediated diseases. Indeed, commensals are important to maintain immune homeostasis and changes in the microbial composition can be responsible for a loss of tolerance. SSc has been shown to be associated with gut dysbiosis and a depletion of commensals. However, although the oral cavity is one of the two largest microbial habitats, only one study (only focusing on Lactobacillus species) has investigated the oral microbiota in SSc. As periodontal dysbiosis is known to induce low-grade systemic inflammation and represents a risk factor for the development of various autoimmune diseases, the relationship between periodontal microbiota composition and SSc merits further exploration.
The aim of this pilot study is to characterize the taxonomic composition and metabolic pathways of the periodontal microbiota in SSc patients and age and sex-matched controls.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Strasbourg, 67000, France
Location status: Recruiting
Sophie JUNG, MD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Common inclusion criteria
Inclusion criteria
for systemic sclerosis patients
Inclusion criteria
for controls
Exclusion criteria
Subgingival plaque will be collected at 6 sites using sterile curettes after removal of supragingival biofilm by brushing. After microbial DNA extraction, whole metagenome will be sequenced.
Time frame: Baseline
Contact information is provided by the study sponsor or research team.
University Hospital, Strasbourg, France
Other
Impact of Systemic Sclerosis on the Periodontal Microbiota: a Pilot Study
Acronym: Periomicross
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07292961
Behavior, Connective Tissue Diseases
Ankara, Altındağ, Turkey (Türkiye)
View Trial DetailsNCT04627857
Connective Tissue Diseases, Scleroderma Systemic
Strasbourg, France
View Trial DetailsNCT07085104
Autoimmune Diseases, Connective Tissue Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07090226
Connective Tissue Diseases, Diffuse Cutaneous Scleroderma
Boston, Massachusetts, United States
View Trial Details